Search

Swivel walkers were commonly prescribed for children with complete thoracic lesion myelomeningocele in the 1970s and 80s, when the incidence of spina bifida in the UK was of the order of 3 per 100,000 live births. The advent of reciprocal walking orthoses provided a more suitable alternative for those with good upper limb and trunk function, and swivel walkers were then used primarily for very young or more severely disabled patients. Pre-natal screening has dramatically reduced the incidence of spina bifida in the UK and subsequently swivel walkers have been used in a wider range of pathology, including spinal muscular atrophy, multiple sclerosis, muscular dystrophy and other neurological conditions that lead to lower limb dysfunction. The detail design of these devices has been adapted to accommodate the specific problems encountered in these conditions. In particular the designs have been updated to: enable very young patients to be more readily fitted at the age of 1 year; allow the walking mechanisms to be conveniently adjusted for easier ambulation when weakness or lack of confidence inhibits performance; permit simple adjustment to a standing frame mode to enhance stability in situations of increased risk; promote manual handling practice that is compatible with the National Health Service (NHS) policy of compliance with relevant regulations. To underpin appropriate prescription and safe supply the NHS Procurement Agency have encouraged the development of a common course for all types of swivel walker.

The growing trend of prescription of reciprocal walking orthoses for children under the age of 5 years has created a requirement for a new design of orthosis in this category. In response to this new demand, a prototype orthosis for infants, incorporating a specially developed hip joint and manufactured as a rehabilitation engineering device within the provisions of the EC Medical Devices Directive, has been produced and tested. A design feature that strongly influences the efficiency of walking is the rigidity of the body brace structure. Monitoring the specific structural performance of the body brace intended for infants showed that it would equal or improve the stiffness achieved in an orthosis for adults. Additionally its strength was comparable with the adult design, which has proven to be safe and reliable in many years of routine prescription. Incorporation of the infant body brace within a complete orthosis provided a structure of more acceptable physical dimensions for these more diminutive patients. The orthosis showed no incipient sign of failure after 100,000 cycles of representative service loading equivalent to that imposed by a 20 kg (5-year-old) patient. The results of structural assessment and cyclic load testing confirm that the design of the orthosis sufficiently satisfies the statutory requirements for devices that are safe and fit for purpose to permit field trials with patients.